Enhanced interleukin-1β and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome

Arthritis and Rheumatism

Volumn 50, Issue 10, 2004, Pages 3329-3333

  Janssen, Riny ^a   Verhard, Els ^a   Lankester, Arjan ^a   Ten Cate, Rebecca ^a   Van Dissel, Jaap T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; CARRIER PROTEIN; CIAS1 PROTEIN, HUMAN; INTERLEUKIN 1;

ARTICLE; ASEPTIC MENINGITIS; BLOOD CELL; CASE REPORT; CELL STIMULATION; CHRONIC NEUROLOGIC CUTANEOUS ARTICULAR SYNDROME; CIAS1 GENE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; FEMALE; GENE; GENE MUTATION; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY DISEASE; PRIORITY JOURNAL; RASH; SCHOOL CHILD; ARTHROPATHY; CHILD; CHRONIC DISEASE; GENETICS; MUTATION; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION; SKIN DISEASE; SYNDROME;

BLOOD CELLS; CARRIER PROTEINS; CASPASE 1; CHILD; CHRONIC DISEASE; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-18; JOINT DISEASES; MUTATION; NERVOUS SYSTEM DISEASES; SKIN DISEASES; SYNDROME;

EID: 5644230842     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20494     Document Type: Article

References (19)

1. Feldmann J, Prieur AM, Quartier P, Berquin P, Cortis E, Teillac-Hamel D, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002;71:198-203.
2. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001;29:301-5.
3. Dode C, Le Du N, Cuisset L, Letourneur F, Berthelot JM, Vaudour G, et al. New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am J Hum Genet 2002;70:1498-506.
4. Manji GA, Wang L, Geddes BJ, Brown M, Merriam S, Al Garawi A, et al. PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-κB. J Biol Chem 2002;277:11570-5.
5. Wang L, Manji GA, Grenier JM, Al Garawi A, Merriam S, Lora JM, et al. PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-κB and caspase-1-dependent cytokine processing. J Biol Chem 2002;277:29874-80.
6. Fantuzzi G, Reed DA, Dinarello CA. IL-12-induced IFN-γ is dependent on caspase-1 processing of the IL-18 precursor. J Clin Invest 1999;104;761-7.
7. Watson RW, Rotstein OD, Parodo J, Bitar R, Marshall JC, William R, et al. The IL-1 β-converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1 β. J Immunol 1998;161:957-62.
8. Kuhn K, Hashimoto S, Lotz M. IL-1 β protects human chondrocytes from CD95-induced apoptosis. J Immunol 2000;164:2233-9.
9. Van der Linden MW, Huizinga TW, Stoeken DJ, Sturk A, Westendorp RG. Determination of tumour necrosis factor-α and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation. J Immunol Methods 1998;218:63-71.
10. Shoham NG, Centola M, Mansfield E, Hull KM, Wood G, Wise CA, et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci U S A 2003;100:13501-6.
11. Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002;46:3340-8.
12. Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP, et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 2003;11:591-604.
13. Masumoto J, Dowds TA, Schaner P, Chen FF, Ogura Y, Li M, et al. ASC is an activating adaptor for NF-κB and caspase-8-dependent apoptosis. Biochem Biophys Res Commun 2003;303:69-73.
14. Stehlik C, Fiorentino L, Dorfleutner A, Bruey JM, Ariza EM, Sagara J, et al. The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor κB activation pathways. J Exp Med 2002;196:1605-15.
15. Stehlik C, Lee SH, Dorfleutner A, Stassinopoulos A, Sagara J, Reed JC. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J Immunol 2003;171:6154-63.
16. Dowds TA, Masumoto J, Chen FF, Ogura Y, Inohara N, Nunez G. Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem Biophys Res Commun 2003;302:575-80.
17. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol Cell 2002;10:417-26.
18. Hawkins PN, Lachmann HJ, McDermott MF. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 2003;348:2583-4.
19. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004;50:607-12.